NCT05765734
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05765734
Title A Study of TAS3351 in NSCLC Patients With EGFRmt (TAS3351)
Acronym TAS3351
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Georgetown University - Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20007 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
University of Texas M. D. Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology - Virginia Fairfax Virginia 22031 United States Details
Institut Gustave Roussy Villejuif Val De Marne 94805 France Details
Universitaetsklinikum Koeln Cologne North Rhine-Westphalia 50937 Germany Details
IEO Istituto Europeo di Oncologia Milan 20141 Italy Details
National Cancer Center Hospital East Kashiwa-shi Chiba 277-8577 Japan Details
Shizuoka Cancer Center Sunto-gun Shizuoka 411-8777 Japan Details
Cancer Institute Hospital of JFCR Kōtoku 135-8550 Japan Details
Antoni van Leeuwenhoek Amsterdam 1066 CX Netherlands Details
Leiden University Medical Center (LUMC) Leiden 2333ZA Netherlands Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 5505 South Korea Details
Hospital Universitari Vall d'Hebron Barcelona 8035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28401 Spain Details
The Christie Hospital Manchester Greater Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field